Ambry Genetics Wins 2026 MedTech Breakthrough Award for CARE Program
Ambry Genetics has won the ‘Best Overall Health Informatics Solution’ award for its CARE Program (Comprehensive, Assessment, Risk, and Education) in the 2026 MedTech Breakthrough Awards, recognizing excellence in digital health among over 5,000 global nominations.
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Ambry Genetics, a leader in clinical genomic testing, and a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), today announced that its CARE Program (Comprehensive, Assessment, Risk, and Education) has been awarded “Best Overall Health Informatics Solution” in the 10th Annual MedTech Breakthrough Awards. The global program recognizes excellence in digital health and medical technology, selecting CARE from more than 5,000 nominations worldwide. The CA